Thanks for your feedback on the AGM which sounds pretty objective to me.
I don't hold ADO on the basis of my opinion that the customers POC1, BBI etc have existing businesses, presumably lucrative, which they don' t want to place at risk. A change in technology to M&G / ADO is a big risk. Hence they want more and more study to confirm risk of a change is minimised. It will never be minimised to zero despite continual research....even if the science risk is almost zero, there are still commercial/logistic and "dont know what you dont know risks." What CEO is going to place a goldmine business at even a small additional risk UNLESS SHE IS FORCED TO?? That's where I see ADO is at, and has been for quite a few years.
I see this situation being broken by ADO only by commercial strategy and hardball tactics than by continual scientific research.
I have no idea on how ADO can achieve that given my assumption that they have offered exclusivity of the science to the various potential customers / markets for some long period. I guess it depends how hardball they played with the original technology development deals...my guess is not very hard as the excitement of getting serious customers "signed up" would have been seen as a major triumph at that stage with insufficient weight at that stage given to the commercial strategies.
The good thing is, from what I read , is that Bouris (spelling) could be up to the challenge and be prepared to take a few commercial /legal risks to force the issue in ADO favour. Again, a guess following my other guess (which probably relegates my view to pure bs), is that the acquisition they are investigating will be a channel to market sufficient to frighten the current "partners to market" to get on board or face a big competitive threat.
Until I see some movement in this direction, I'm out and ADO isnt worth anything like $100M.
I'm watching though, because there is potential. Trouble is, my bank doesn't take "potential"as a deposit.
- Forums
- ASX - By Stock
- ADO
- RReflections on AGM presentation and Q&A
ADO
anteotech ltd
Add to My Watchlist
7.14%
!
1.3¢

RReflections on AGM presentation and Q&A, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.3¢ |
Change
-0.001(7.14%) |
Mkt cap ! $35.16M |
Open | High | Low | Value | Volume |
1.3¢ | 1.4¢ | 1.3¢ | $1.616K | 122.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 511480 | 1.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.4¢ | 1570790 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 511480 | 0.013 |
9 | 2624989 | 0.012 |
8 | 2308174 | 0.011 |
9 | 3859000 | 0.010 |
11 | 2103777 | 0.009 |
Price($) | Vol. | No. |
---|---|---|
0.014 | 1570790 | 6 |
0.015 | 4611116 | 12 |
0.016 | 1427582 | 2 |
0.017 | 224509 | 5 |
0.018 | 499000 | 3 |
Last trade - 11.06am 02/07/2025 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
The Watchlist
AFP
AFT PHARMACEUTICALS LIMITED
Dr. Hartley Atkinson, MD
Dr. Hartley Atkinson
MD
Previous Video
Next Video
SPONSORED BY The Market Online